The incidence of lower respiratory tract infections and pneumococcal vaccination status in adults in flemish primary care

References

• Vos T, Barber RM, Bell B, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;386(9995):743–800.
   Google Scholar
• Macfarlane J, Holmes W, Gard P, et al. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax. 2001;56(2):109–114.
   Google Scholar
• Rozenbaum MH, Pechlivanoglou P, van der Werf TS, et al. The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis. Eur J Clin Microbiol Infect Dis. 2013 Mar;32(3):305–316. PubMed PMID: 23242464; eng.
   Google Scholar
• Torres A, Peetermans WE, Viegi G, et al. Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax. 2013 Nov;68(11):1057–1065. PubMed PMID: 24130229; PubMed Central PMCID: PMCPMC3812874. eng.
   Google Scholar
• Flamaing J, De Backer W, Van Laethem Y, et al. Pneumococcal lower respiratory tract infections in adults: an observational case-control study in primary care in Belgium. BMC Fam Pract. 2015 May 27;16:66. 10.1186/s12875-015-0282-1. PubMed PMID: 26012956; PubMed Central PMCID: PMCPMC4443659. eng.
   Google Scholar
• Naghavi M, Wang H, Lozano R, et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;385(9963):117–171.
   Google Scholar
• WHO. 23-valent pneumococcal polysaccharide vaccine. WHO position paper. Wkly Epidemiol Rec. 2008 Oct 17;83(42):373–384. PubMed PMID: 18927997; eng fre.
   Google Scholar
• Joseph C, Togawa Y, Shindo N. Bacterial and viral infections associated with influenza. Influenza Other Respir Viruses. 2013 Sep;7 Suppl 2:105–113. PubMed PMID: 24034494; eng.
   Google Scholar
• Jose RJ, Brown JS. Adult pneumococcal vaccination: advances, impact, and unmet needs. Curr Opin Pulm Med. 2017 May;23(3):225–230. PubMed PMID: 28198725; eng.
   Google Scholar
• Pitsiou GG, Kioumis IP. Pneumococcal vaccination in adults: does it really work? Respir Med. 2011 Dec;105(12):1776–1783. PubMed PMID: 21816596; eng. .
   Google Scholar
• Falkenhorst G, Remschmidt C, Harder T, et al. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPV23) against pneumococcal disease in the elderly: systematic review and meta-analysis. PLoS One. 2017;12(1):e0169368. PubMed PMID: 28061505; PubMed Central PMCID: PMCPMC5218810. eng.
   Google Scholar
• Bonten MJ, Huijts SM, Bolkenbaas M, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med. 2015 Mar 19;372(12):1114–1125. PubMed PMID: 25785969; eng.
   Google Scholar
• Torres A, Blasi F, Dartois N, et al. Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease. Thorax. 2015 Oct;70(10):984–989. PubMed PMID: 26219979; PubMed Central PMCID: PMCPMC4602259. eng.
   Google Scholar
• Said MA, Johnson HL, Nonyane BA, et al. Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One. 2013;8(4):e60273. PubMed PMID: 23565216; PubMed Central PMCID: PMC3615022.
   Google Scholar
• Shea KM, Edelsberg J, Weycker D, et al. Rates of pneumococcal disease in adults with chronic medical conditions. Open Forum Infect Dis. 2014 Mar;1(1):ofu024. PubMed PMID: 25734097; PubMed Central PMCID: PMCPMC4324183. eng.
   Google Scholar
• Gezondheidsraad H. Vaccinatie tegen pneumokokken; 2014. Available from: https://www.zorg-en-gezondheid.be/sites/default/files/atoms/files/Vaccinatie%20tegen%20pneumokokken%20-%20volwassenen%20%282014%29%20%28HGR%209210%29.pdf
   Google Scholar
• Theidel U, Kuhlmann A, Braem A. Pneumococcal vaccination rates in adults in Germany: an analysis of statutory health insurance data on more than 850,000 individuals. Dtsch Arztebl Int. 2013 Nov 01;110(44):743–750. PubMed PMID: 24280430; PubMed Central PMCID: PMCPMC3831240. eng.
   Google Scholar
• Rouveix E, Gherissi Cherni D, Dupont C, et al. Streptococcus pneumoniae vaccinal coverage in hospitalized elderly patients in France. Med Mal Infect. 2013 Jan;43(1):22–27. PubMed PMID: 23246143.
   Google Scholar
• Lu PJ, Nuorti JP. Uptake of pneumococcal polysaccharide vaccination among working-age adults with underlying medical conditions, United States, 2009. Am J Epidemiol. 2012 Apr 15;175(8):827–837. PubMed PMID: 22403807; eng.
   Google Scholar
• Maruyama T, Taguchi O, Niederman MS, et al. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. BMJ. 2010 Mar 08;340:c1004. PubMed PMID: 20211953; PubMed Central PMCID: PMCPMC2834887. eng.
   Google Scholar
• Ochoa-Gondar O, Vila-Corcoles A, Rodriguez-Blanco T, et al. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged≥ 60 years: 3 years of follow-up in the CAPAMIS study. Clin Infect Dis. 2014;58(7):909–17.
   Google Scholar
• Schiffner-Rohe J, Witt A, Hemmerling J, et al. Efficacy of PPV23 in preventing pneumococcal pneumonia in adults at increased risk-a systematic review and meta-analysis. PloS One. 2016;11:1.
   Google Scholar
• Kraicer-Melamed H, O’Donnell S, Quach C. The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: A systematic review and meta-analysis. Vaccine. 2016 Mar 18;34(13):1540–1550. PubMed PMID: 26899372; eng.
   Google Scholar
• Bonten MJ, Huijts SM, Bolkenbaas M, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med. 2015;372(12):1114–1125.
   Google Scholar
• Ewald H, Briel M, Vuichard D, et al. The clinical effectiveness of pneumococcal conjugate vaccines. Dtsch Arztebl Int. 2016 Mar 4;113(9):139–146. PubMed PMID: 26987462; PubMed Central PMCID: PMC4802351.
   Google Scholar
• Truyers C, Goderis G, Dewitte H, et al. The Intego database: background, methods and basic results of a Flemish general practice-based continuous morbidity registration project. BMC Med Inform Decis Mak. 2014 Jun 06;14:48. PubMed PMID: 24906941; PubMed Central PMCID: PMCPMC4067630. eng.
   Google Scholar
• Bartholomeeusen S, Kim CY, Mertens R, et al. The denominator in general practice, a new approach from the Intego database. Fam Pract. 2005 Aug;22(4):442–447. PubMed PMID: 15964863; eng.
   Google Scholar
• Flamaing J. Vaccinaties en ouderen: stand van zaken. Tijdschrift Voor Geneeskunde. 2005;61(24):1751.
   Google Scholar
• Tafforeau J. Vaccinatie. In: Demarest S, Charafeddine R, editors. Gezondheidsenquête 2013. Rapport 5: preventie. Brussel: WIV-ISP; 2015:125–207.
   Google Scholar
• Bayas J-M, Izquierdo C, Ruiz L, et al. Validity of self-reported pneumococcal vaccination status in the elderly in Spain. Vaccine. 2009;27(34):4560–4564.
   Google Scholar
• Grimaldi‐Bensouda L, Aubrun E, Leighton P, et al. Agreement between patients’ self‐report and medical records for vaccination: the PGRx database. Pharmacoepidemiol Drug Saf. 2013;22(3):278–285.
   Google Scholar
• Kroneman MW, van Essen GA, Tacken MA, et al. Does a population survey provide reliable influenza vaccine uptake rates among high-risk groups? A case-study of The Netherlands. Vaccine. 2004;22(17):2163–2170.
   Google Scholar
• Llupià A, García-Basteiro AL, Mena G, et al. Vaccination behaviour influences self-report of influenza vaccination status: a cross-sectional study among health care workers. PloS One. 2012;7(7):e39496.
   Google Scholar
• Mangtani P, Shah A, Roberts J. Validation of influenza and pneumococcal vaccine status in adults based on self-report. Epidemiol Infect. 2007;135(1):139–143.
   Google Scholar
• Wagenvoort GH, Knol MJ, de Melker HE, et al. Risk and outcomes of invasive pneumococcal disease in adults with underlying conditions in the post-PCV7 era, The Netherlands. Vaccine. 2016 Jan 12;34(3):334–340. PubMed PMID: 26647289; eng.
   Google Scholar
• Selya-Hammer C, Fleming D, Jiang Y, et al. Co-administration of PPV23 and influenza vaccines in England and Wales: a study based on the royal college of general practitioners sentinel surveillance network. J Vaccines Immun. 2015;1(2):043. 49:043.
   Google Scholar
• Castiglia P. Recommendations for pneumococcal immunization outside routine childhood immunization programs in Western Europe. Adv Ther. 2014 Oct;31(10):1011–1044. PubMed PMID: 25300593; PubMed Central PMCID: PMCPMC4209094. eng.
   Google Scholar
• Hak E, Rovers MM, Kuyvenhoven MM, et al. Incidence of GP-diagnosed respiratory tract infections according to age, gender and high-risk co-morbidity: the second Dutch national survey of general practice. Fam Pract. 2006 Jun;23(3):291–294. PubMed PMID: 16464869; eng.
   Google Scholar
• Millett ER, Quint JK, Smeeth L, et al. Incidence of community-acquired lower respiratory tract infections and pneumonia among older adults in the United Kingdom: a population-based study. PLoS One. 2013;8(9):e75131. PubMed PMID: 24040394; PubMed Central PMCID: PMCPMC3770598. eng.
   Google Scholar
• Mocke L, Höffken G, Schmitt J. et al. Burden of ambulatory and hospitalized community-acquired pneumonia: a population based study in Germany. A62. CLINICAL ASPECTS OF CAP, HCAP, HAP, AND VAP. Am Thoracic Soc. 2016(193):A2087.
   Google Scholar
• Unit B. The incidence rate and economic burden of community-acquired pneumonia in a working-age population; 2013.
   Google Scholar
• Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax. 2012 Jan;67(1):71–79. PubMed PMID: 20729232; eng.
   Google Scholar
• Lipsitch M, Jha A, Simonsen L. Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies. Int J Epidemiol. 2016 Dec 01;45(6):2060–2074. PubMed PMID: 27453361; eng.
   Google Scholar
• Simonsen L, Taylor RJ, Viboud C, et al. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis. 2007 Oct;7(10):658–666. PubMed PMID: 17897608; eng.
   Google Scholar
• van Vugt SF, Verheij TJ, de Jong PA, et al. Diagnosing pneumonia in patients with acute cough: clinical judgment compared to chest radiography. Eur Respir J. 2013 Oct;42(4):1076–1082. PubMed PMID: 23349450.
   Google Scholar
• Bello S, Menendez R, Torres A, et al. Tobacco smoking increases the risk for death from pneumococcal pneumonia. Chest. 2014 Oct;146(4):1029–1037. PubMed PMID: 24811098; eng.
   Google Scholar
• Hoeck S, van der Heyden J, Geerts J, et al. Preventive care use among the Belgian elderly population: does socio-economic status matter? Int J Environ Res Public Health. 2014 Jan;11(1):355–372. PubMed PMID: 24368427; PubMed Central PMCID: PMCPMC3924448.
   Google Scholar